06
Mar
Q&A with Eric Lefkofsky, CEO of Tempus and Co-founder of Groupon
“Treating a cancer patient without the benefit of modern software is the same as driving at night without headlights”...
20
Feb
PMWC Michigan – Big Data in Action: Data-Driven Insights in the Clinic
We are excited to launch the first Precision Medicine World Conference (PMWC) at the University of Michigan June 6-7, 2018....
24
Jan
Q&A with Susan A. Murphy, Harvard University
Q: Your lab develops experimental trial designs and data analysis methods for increasing the usefulness of mobile health interventions. Can you please give examples how these trials are being used in the areas of substance abuse, physical activity, or helping people quit smoking?...
18
Jan
Q&A with Dr. Dara Richardson-Heron, Chief Engagement Officer, All of Us
Q: Your reputation for passion about engaging and empowering people precedes you. Can you please describe your role at the All of Us Research Program?...
15
Jan
Late breaking: Dawn Barry leaves Illumina to lead LunaDNA -Blockchain Disrupting Healthcare Industry
“Every individual holds a valuable piece of the puzzle to understand disease and health, and researchers are all in need of more data. Discovery is hindered by putting the majority of data into small silos. Breaking down data silos and bringing individuals together will more...
14
Jan
Interview Dawn Barry the new President and Co-founder of LunaDNA
Q: In a sentence, what is Luna DNA going to do?...
11
Jan
JPM18: Edico Genome, Illumina, Invitae, Regeneron, Thermo Fisher Scientific,… and the list goes on
It’s been an announcement-packed JPMorgan Healthcare Conference in San Francisco this week!...
03
Jan
At PMWC 2018 Silicon Valley CMS Administrator Seema Verma Discusses the Future of Health Care
Genomics-based testing or new immunotherapies that revolutionize cancer care are changing how we approach disease...
02
Jan
Interview with Dr. Frank Lee, Global Healthcare & Life Sciences Industry Leader at IBM; Chief Architect, IBM Reference Architecture for Genomics – Speaker at PMWC 2018 Silicon Valley
Q: As a pioneer in high performance architectures for genomic research what are the biggest challenges that you see clients dealing with as they invest in precision medicine initiatives? ...
01
Jan
Q&A with Ira Mellman, PhD, Vice President, Cancer Immunology, Genentech – Speaker at PMWC 2018 Silicon Valley
Q: Immunotherapy is considered a huge game-changer and holds a lot of promises. Is the hype around immunotherapy justified? What are some of the exciting developments in the recent years?...
